![Gregory Bowles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregory Bowles
Directeur Général chez Aquyre Biosciences, Inc.
Postes actifs de Gregory Bowles
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aquyre Biosciences, Inc.
![]() Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Directeur/Membre du Conseil | 05/12/2023 | - |
Directeur Général | 05/12/2023 | - | |
President | 05/12/2023 | - |
Historique de carrière de Gregory Bowles
Anciens postes connus de Gregory Bowles
Sociétés | Poste | Début | Fin |
---|---|---|---|
FlexDex, Inc.
![]() FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Fondateur | - | 01/01/2020 |
Sales & Marketing | - | 01/01/2020 | |
US Department of the Navy (District of Columbia) | Corporate Officer/Principal | - | - |
JOHNSON & JOHNSON | Sales & Marketing | - | - |
INTUITIVE SURGICAL, INC. | Sales & Marketing | - | - |
EndoGastric Solutions, Inc.
![]() EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Sales & Marketing | - | - |
Formation de Gregory Bowles
Northwood University (Michigan) | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Sales & Marketing | 4 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
INTUITIVE SURGICAL, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
EndoGastric Solutions, Inc.
![]() EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Health Technology |
US Department of the Navy (District of Columbia) | Government |
FlexDex, Inc.
![]() FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Health Technology |
Aquyre Biosciences, Inc.
![]() Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Health Services |
- Bourse
- Insiders
- Gregory Bowles
- Expérience